Optimal revascularization strategy in patients with three-vessel disease and/or left main disease The 2-year Outcomes of the SYNTAX Trial A. Pieter Kappetein,
Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? The TRENDS Study Taya V. Glotzer, Emile.
Primary Results from the SMART AV DELAY Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac.
Status Update 2009 Michael J. Fisch, MD, MPH, FACP Medical Director.
Keith Aaronson, Mark Slaughter, Edwin McGee, William Cotts ...
Truvada Randomized Trial of HBIG Withdrawal February 7 2014
A First-in-human, First-in-class, Phase I Study of Systemic Hedgehog Pathway Antagonist, GDC-0449, in Patients with Advanced Solid Tumors P.M. LoRusso,
Alexander GG Turpie On behalf of Kenneth A Bauer, Scott D Berkowitz, Fred D Cushner, Bruce L Davidson, Michael Gent, Louis M Kwong, Michael R Lassen, Paul.
Interventions in Pediatric Obesity Endocrinology Rounds 3 rd June, 2009 Cheril Clarson.
WHAT DOES IT TAKE? 5 Lessons Learned from Supporting Evidence-based Home Visiting to Prevent Child Maltreatment Virginia Home Visiting Consortium Meeting.
FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.